Global Human Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 09-Aug-2018
No. of pages: 98
Inquire Before Buying

This report studies the global market size of Human Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Vaccine in these regions.

This research report categorizes the global Human Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person's immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. 

A major trend being witnessed in the global human vaccines market is the increase in strategic alliances. Increase in threat from regional vendors in developing countries may cause price erosion and may compel major players to operate under low-margin models. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.

The growth of the global human vaccines market is driven by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines. Similarly, the increase in the prevalence of infectious diseases and cancers is also leading to market growth.

In 2017, the global Human Vaccine market size was 14100 million US$ and is forecast to 30600 million US in 2025, growing at a CAGR of 10.2% from 2018. The objectives of this study are to define, segment, and project the size of the Human Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Human Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Human Vaccine include

- GlaxoSmithKline

- Merck

- Pfizer

- Sanofi

- AstraZeneca

- Bavarian Nordic

- Baxter

- Bharat Biotech

Market Size Split by Type

- Conjugate

- Recombinant

- Inactivated

- Combination

- Attenuated

- Others

Market Size Split by Application

- Pediatrics

- Adolescents

- Adults

- Geriatrics

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Human Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Human Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Human Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Human Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Human Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Human Vaccine are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Human Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Human Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Vaccine Market Size Growth Rate by Type
1.4.2 Conjugate
1.4.3 Recombinant
1.4.4 Inactivated
1.4.5 Combination
1.4.6 Attenuated
1.4.7 Others
1.5 Market by Application
1.5.1 Global Human Vaccine Market Size Growth Rate by Application
1.5.2 Pediatrics
1.5.3 Adolescents
1.5.4 Adults
1.5.5 Geriatrics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size
2.1.1 Global Human Vaccine Revenue 2016-2025
2.1.2 Global Human Vaccine Sales 2016-2025
2.2 Human Vaccine Growth Rate by Regions
2.2.1 Global Human Vaccine Sales by Regions
2.2.2 Global Human Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Human Vaccine Sales by Manufacturers
3.1.1 Human Vaccine Sales by Manufacturers
3.1.2 Human Vaccine Sales Market Share by Manufacturers
3.1.3 Global Human Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Human Vaccine Revenue by Manufacturers
3.2.1 Human Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Human Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Human Vaccine Price by Manufacturers
3.4 Human Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Human Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Human Vaccine Sales by Type
4.2 Global Human Vaccine Revenue by Type
4.3 Human Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Human Vaccine Breakdown Data by Application
6 North America
6.1 North America Human Vaccine by Countries
6.1.1 North America Human Vaccine Sales by Countries
6.1.2 North America Human Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Vaccine by Type
6.3 North America Human Vaccine by Application
6.4 North America Human Vaccine by Company
7 Europe
7.1 Europe Human Vaccine by Countries
7.1.1 Europe Human Vaccine Sales by Countries
7.1.2 Europe Human Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Vaccine by Type
7.3 Europe Human Vaccine by Application
7.4 Europe Human Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Human Vaccine by Countries
8.1.1 Asia Pacific Human Vaccine Sales by Countries
8.1.2 Asia Pacific Human Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Vaccine by Type
8.3 Asia Pacific Human Vaccine by Application
8.4 Asia Pacific Human Vaccine by Company
9 Central & South America
9.1 Central & South America Human Vaccine by Countries
9.1.1 Central & South America Human Vaccine Sales by Countries
9.1.2 Central & South America Human Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Vaccine by Type
9.3 Central & South America Human Vaccine by Application
9.4 Central & South America Human Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Human Vaccine by Countries
10.1.1 Middle East and Africa Human Vaccine Sales by Countries
10.1.2 Middle East and Africa Human Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Vaccine by Type
10.3 Middle East and Africa Human Vaccine by Application
10.4 Middle East and Africa Human Vaccine by Company
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Human Vaccine
11.1.4 Human Vaccine Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Human Vaccine
11.2.4 Human Vaccine Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Human Vaccine
11.3.4 Human Vaccine Product Description
11.3.5 Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Human Vaccine
11.4.4 Human Vaccine Product Description
11.4.5 Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Human Vaccine
11.5.4 Human Vaccine Product Description
11.5.5 Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Human Vaccine
11.6.4 Human Vaccine Product Description
11.6.5 Recent Development
11.7 Baxter
11.7.1 Baxter Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Human Vaccine
11.7.4 Human Vaccine Product Description
11.7.5 Recent Development
11.8 Bharat Biotech
11.8.1 Bharat Biotech Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Human Vaccine
11.8.4 Human Vaccine Product Description
11.8.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Human Vaccine Raw Material
13.1.2 Human Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Human Vaccine
Figure Global Human Vaccine Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Human Vaccine Production Market Share by Types (Product Category) in 2017
Figure Conjugate Product Picture
Table Major Manufacturers of Conjugate
Figure Recombinant Product Picture
Table Major Manufacturers of Recombinant
Figure Inactivated Product Picture
Table Major Manufacturers of Inactivated
Figure Combination Product Picture
Table Major Manufacturers of Combination
Figure Attenuated Product Picture
Table Major Manufacturers of Attenuated
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Human Vaccine Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Pediatrics
Figure Adolescents
Figure Adults
Figure Geriatrics
Figure Human Vaccine Report Years Considered
Figure Global Human Vaccine Market Size 2016-2025 (Million US$)
Figure Global Human Vaccine Sales 2016-2025 (K MT)
Table Global Human Vaccine Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Human Vaccine Sales by Regions 2016-2025 (K MT)
Table Global Human Vaccine Sales Market Share by Regions 2016-2025
Figure Global Human Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Human Vaccine Sales Market Share by Regions
Table Global Human Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Human Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Human Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Human Vaccine Revenue Market Share by Regions
Table Global Human Vaccine Sales by Manufacturers (2016-2018) (K MT)
Table Global Human Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Human Vaccine Sales Share by Manufacturers in 2017
Table Human Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Human Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Human Vaccine Value Share by Manufacturers in 2017
Table Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Human Vaccine Price (2016-2018) (USD/MT)
Table Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Vaccine Product Category
Table Date of International Manufacturers Enter into Human Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Vaccine Sales by Type (2016-2025) (K MT)
Table Global Human Vaccine Sales Share by Type (2016-2025)
Figure Global Human Vaccine Sales Market Share by Type (2016-2025)
Figure Global Human Vaccine Sales Market Share by Type in 2017
Table Global Human Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Human Vaccine Revenue Share by Type (2016-2025)
Figure Global Human Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Human Vaccine Revenue Market Share by Type in 2017
Table Human Vaccine Price by Type 2013-2018 (USD/MT)
Table Global Human Vaccine Sales by Application (2016-2025) (K MT)
Table Global Human Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Human Vaccine Market Share by Application (2016-2025)
Figure Global Sales Human Vaccine Market Share by Application (2016-2025)
Figure North America Human Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure North America Human Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Human Vaccine Sales by Countries (2016-2025) (K MT)
Table North America Human Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Human Vaccine Sales Market Share by Countries
Table North America Human Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Human Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Human Vaccine Revenue Market Share by Countries
Figure United States Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure United States Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Canada Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Human Vaccine Sales by Type (2016-2025) (K MT)
Table North America Human Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Human Vaccine Market Share by Type
Table North America Human Vaccine Sales by Application (2016-2025) (K MT)
Table North America Human Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Human Vaccine Market Share by Application
Table North America Human Vaccine Sales by Company (2016-2018) (K MT)
Table North America Human Vaccine Sales Market Share by Company (2016-2018)
Figure North America Human Vaccine Sales Market Share by Company in 2017
Figure Europe Human Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Europe Human Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Human Vaccine Sales by Countries (2016-2025) (K MT)
Table Europe Human Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Human Vaccine Sales Market Share by Countries
Table Europe Human Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Human Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Human Vaccine Revenue Market Share by Countries
Figure Germany Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Germany Human Vaccine Revenue Growth Rate (2016-2025) (K MT)
Figure France Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure France Human Vaccine Revenue Growth Rate (2016-2025) (K MT)
Figure UK Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure UK Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Italy Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Russia Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Human Vaccine Sales by Type (2016-2025) (K MT)
Table Europe Human Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Human Vaccine Market Share by Type
Table Europe Human Vaccine Sales by Application (2016-2025) (K MT)
Table Europe Human Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Human Vaccine Market Share by Application
Table Europe Human Vaccine Sales by Company (2016-2018) (K MT)
Table Europe Human Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Human Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Human Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Human Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Human Vaccine Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Human Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Human Vaccine Sales Market Share by Countries
Table Asia Pacific Human Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Human Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Human Vaccine Revenue Market Share by Countries
Figure China Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure China Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Japan Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Korea Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure India Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Australia Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Human Vaccine Sales by Type (2016-2025) (K MT)
Table Asia Pacific Human Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Human Vaccine Market Share by Type
Table Asia Pacific Human Vaccine Sales by Application (2016-2025) (K MT)
Table Asia Pacific Human Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Human Vaccine Market Share by Application
Table Asia Pacific Human Vaccine Sales by Company (2016-2018) (K MT)
Table Asia Pacific Human Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Human Vaccine Sales Market Share by Company in 2017
Figure Central & South America Human Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Human Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Human Vaccine Sales by Countries (2016-2025) (K MT)
Table Central & South America Human Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Human Vaccine Sales Market Share by Countries
Table Central & South America Human Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Human Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Human Vaccine Revenue Market Share by Countries
Figure Brazil Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Human Vaccine Sales by Type (2016-2025) (K MT)
Table Central & South America Human Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Human Vaccine Market Share by Type
Table Central & South America Human Vaccine Sales by Application (2016-2025) (K MT)
Table Central & South America Human Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Human Vaccine Market Share by Application
Table Central & South America Human Vaccine Sales by Company (2016-2018) (K MT)
Table Central & South America Human Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Human Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Human Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Human Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Human Vaccine Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Human Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Human Vaccine Sales Market Share by Countries
Table Middle East and Africa Human Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Human Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Human Vaccine Revenue Market Share by Countries
Figure GCC Countries Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Human Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Human Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Human Vaccine Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Human Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Human Vaccine Market Share by Type
Table Middle East and Africa Human Vaccine Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Human Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Human Vaccine Market Share by Application
Table Middle East and Africa Human Vaccine Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Human Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Human Vaccine Sales Market Share by Company in 2017
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Bavarian Nordic Company Details
Table Bavarian Nordic Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Bavarian Nordic Recent Development
Table Baxter Company Details
Table Baxter Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Baxter Recent Development
Table Bharat Biotech Company Details
Table Bharat Biotech Human Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Bharat Biotech Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Human Vaccine Value Chain
Table Typical Suppliers of Key Human Vaccine Raw Material
Table Human Vaccine Customers List
Table Human Vaccine Sales Channels
Table Human Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Botulinum Toxin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 113
    Botulinum toxin (BTX) or Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research. Scope of the Report: This report focuses on the Botulinum Toxin in glo......
  • Global Brain Health Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Brain health supplements are used to enhance memory, attention, mood, creativity, motivation in healthy individuals. Increasing awareness among college students, scientists, entrepreneurs and investment bankers are opting for memory enhancers to sharpen their minds to gain an edge on the competition. Scope of the Report: This report focuses on the Brain Health Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle E......
  • Global Morphine Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 113
    Morphine is a pain medication of the opiate family which is found naturally in a number of plants and animals. As per the International Narcotics Control Board, 92 % of the worlds morphine is consumed by 17% of the worlds population, while the rest of the world population consumes around 8% of morphine. The growth of the market for is driven by factors such as lifestyle changes that lead to pain and growth in number of surgical procedures as the drug is prescribed for pain relief p......
  • Global Levofloxacin Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 116
    Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is available by mouth, intravenously, and in eye drop form. Factors such as increasing incidences of bacterial inf......
  • Global Tamoxifen Citrate Market Research Report 2018
    Published: 19-Oct-2018        Price: US 2900 Onwards        Pages: 115
    This report studies the global Tamoxifen Citrate market status and forecast, categorizes the global Tamoxifen Citrate market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Cayman Chemical Company - Agvar Chemicals Inc - Cayman Chemical Company......
  • Global Bioengineered Protein Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Scope of the Report: This report focuses on the Bioengineered Protein Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products ......
  • Global Minocycline Hydrochloride Market Insights, Forecast to 2025
    Published: 18-Oct-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Minocycline Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Minocycline Hydrochloride in these regions. This research report categorizes the global Minocycline Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global and United States Opioid-induced Constipation Market Research by Company, Type & Application 2013-2025
    Published: 18-Oct-2018        Price: US 2000 Onwards        Pages: 109
    Summary Market Segment as follows: By Type - Solid - Liquid By Application - Drugstore - Hospital - Others By Company - AstraZeneca - Takeda Pharmaceutical - Valeant Pharmaceuticals International - Abbott - Bayer - Boehringer Ingelheim - C.B. Fleet - Cosmo Pharmaceuticals - Daewoong - Daiichi Sankyo - GlaxoSmithKline - Ironwoo......
  • Global Budesonide Sprays Market Insights, Forecast to 2025
    Published: 18-Oct-2018        Price: US 3900 Onwards        Pages: 125
    In 2017, the global Budesonide Sprays market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Budesonide Sprays market based on company, product type, application and key regions. This report studies the global market size of Budesonide Sprays in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs